Net profit of Gland Pharma declined 3.06% to Rs 186.54 crore in the quarter ended March 2025 as against Rs 192.42 crore during the previous quarter ended March 2024. Sales declined 7.32% to Rs 1424.91 crore in the quarter ended March 2025 as against Rs 1537.45 crore during the previous quarter ended March 2024.
For the full year,net profit declined 9.57% to Rs 698.53 crore in the year ended March 2025 as against Rs 772.46 crore during the previous year ended March 2024. Sales declined 0.85% to Rs 5616.50 crore in the year ended March 2025 as against Rs 5664.72 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 1424.91 | 1537.45 | -7 | 5616.50 | 5664.72 | -1 |
| OPM % | 24.39 | 23.33 | - | 22.59 | 23.53 | - |
| PBDT | 384.09 | 390.84 | -2 | 1440.53 | 1477.11 | -2 |
| PBT | 288.33 | 298.23 | -3 | 1062.66 | 1132.54 | -6 |
| NP | 186.54 | 192.42 | -3 | 698.53 | 772.46 | -10 |